I-Cannabidiol, okanye i-CBD, isithako esisebenzayo kwi- isnabisi yeziyobisi, eyaziwa ngokuba yi-marijuana. I-CBD yinto ebonakalayo yesibini kakhulu eyaziwayo yentsangu, emva kwe-delta-9-tetrahydrocannibinol, okanye i-THC. I-Marijuana iqulethe izinto ezingaphezulu kwama-400 ezahlukileyo, kunye ne-THC kunye ne-CBD zimbini zee-molecule ezingama-60 ezihlukeneyo ze-cannabinoid.
Iimpembelelo ze-Cannabidiol
Kukho ubungqina obuninzi bokuba i-CBD inokuba neenzuzo zonyango, ezibandakanya i-anticonvulsive, sedative, hypnotic, antipsychotic kunye neproproductive properties.
Ibuye ibe nomthelela ochasayo, owenziwe kwizifundo zezilwanyana eziliqela eziliqela ezili-120 ze-aspirin (i-acetylsalicylic acid). Ngenxa yokuba i-CBD ivelisa imiphumo yezinto eziphilayo ngaphandle kokwenza ngokuphawulekayo kwi-receptors yengqondo ye-cannabinoid, ayikho imbangela yeengxaki ezingathandekiyo ze-psychotropic eziphawulekayo kwezinye iziphumo ze-marijuana. Oku kunika ithuba eliphezulu kakhulu lokusetyenziswa ekuphuhlisweni kweendlela ezahlukeneyo zonyango.
Ucwaningo oluthelekisa i-THC kunye ne-CBD lubonise ukuba ezinye zezinto ezingathandekiyo ze-marijuana eziphezulu, ezinjengexhala kunye ne- paranoia , kubonakala zibangelwa yi-THC, kwaye zinciphisa i-CBD. Nangona uphando olunzima, uphando lubonise imiphumo ye-neuroprotective ye-CBD. Uphando oluqhathaniswa nobuchopho be-marijuana abangapheliyo kunye nabathathi be-CBD kwiisampuli zeenwele zibonise ukuba, ngelixa i-THC ibonakala ibe nefuthe le-neurotoxic, iyanciphisa umbandela kwiindawo zobuchopho, i-CBD ibonakala ibe nefuthe le-neuroprotective kwiindawo ezifanayo yengqondo.
Olunye uhlolisiso olujongene nemiphumo yeziyobisi ezahlukahlukeneyo ekuphuhliseni ukunyuka kwengqondo kubonisa ukuba i-CBD ingaba nemiphumo emihle, kubandakanywa nokunciphisa iimpawu zengqondo yengqondo kubantu abanezifo ze-Parkinson. Nangona kunjalo, kusekuqaleni ukuthetha ukuba i-CBD ingasetyenziselwa ukuthintela ukugula komzimba, imeko apho inkqubo yezokwelapha iyanzima ukujamelana nayo njengoko ifikeleleke kwingqungquthela yobuninzi phakathi kwabantu abadala.
Kukho uphando lokubonisa ukuba i-CBD inganciphisa iimpawu zengqondo yengqondo kubantu abanesifo sika-Parkinson.
Inani le-Cannabidiol kwi-Cannabis
Nangona kubonakala ukuba i-CBD ibonakala ngathi i-agent efanelekileyo kunye nayo kunye nomntu onokuguqula ezinye zeengxaki ezimbi ze-THC, iingxelo zendlela ama-ornabis ashintshile ngayo kwiminyaka elishumi yokuqala yekhulu lama-21 ephathelele. Imibiko engumlinganiselo we-THC kunye ne-CDB kwi-cannabis ibe malunga ne-4% yento nganye. Ngokwahlukileyo, "i-potency ephezulu" yentsholongwane yegunju eye yaphuhliswa kungekudala, njenge-sinsemilla, okanye "skunk," kuthiwa iqulethe i-16-22% ye-THC, ibe ngaphantsi kwe-0.1% ye-CBD. Oku kungachaza ukwanda kwangoko kwimiba enxulumene nesifo senzululwazi .
> Imithombo:
> Demirakca, T., Sartorius, A., Ende, G., Meyer, N., Welzel, H., Skopp, G., Mann, K. & Hermann, D. "Ukunciphisa imfene kwi-hippocampus yabasebenzisi be-cannabis : Iziphumo ezikhuselekileyo zokukhusela i-cannabidiol. " Ukuxhomekeka kweziyobisi kunye noTywala , 114: 242-5. 2011.
> Englund, A., Morrison, P., Nottage, J., Hague, D., Kane, F., Bonaccorso, S., Stone, J., Reichenberg, A., Brenneisen, R., Holt, D. , IHoilding, A., Walker, L., Murray, R., no-Kapur, S. "I-Cannabidiol inqanda i-THC-impawu ze-paranoid kunye nokukhubazeka kweememori ezixhomekeke kwi-hippocampal." Umbhalo we-Psychopharmacology [inthanethi] 1-9. 2012.
> Nceda, uMe & Perry, E. "Indima yeePhytochemicals kwiNyango kunye nokuCandwa kweDementia." Iziyobisi kunye nokuguga 28: 439-468. 2011.
> Scuderi, C., Filippis, D., Iuvone, T., Blasio, A., Steardo, A. & Esposito, G. "I-Cannibidiol kwipilisi: ukuhlaziywa kwamandla ayo okwelapha kwiingxaki ze-CNS." Phytotherapy Research 23: 597-602. 2009.
> Williamson, E. & Evans, F. "Iingenabinoid in Practice Practice." Iziyobisi 60: 1303-1314. 2000.
> Zuardi, A., Crippa, J., Hallak, J., et al. "I-Cannabidiol yokunyanga kwengqondo yengqondo kwisifo sikaParkinson." J Psychopharmacol 23: 979-83. 2009